Certified by Founder
                                        Lodge
                                        
                                        
                                    
                                    
                                    Myricx Bio
                                                                                start up
                                                                            
                                    
                                                                                                                                    
                                                                                                United Kingdom
                                                 -                                                 London
                                                                                            
                                                                                    - 09/07/2024
 - Series A
 - $115,246,800
 
We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer.
- Industry Biotechnology Research
 - Website https://myricxbio.com/
 - LinkedIn https://www.linkedin.com/company/myricx-pharma-ltd/
 
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                            
                                AUI™ (Augmented Intelligence) |  $20,000,000  | (Nov 4, 2025)
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                            
                                                
                                                    
                                                    
                                                    
                                                    
                                                    
                                                    
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                Mem0 |  $24,000,000  | (Oct 30, 2025)
                                                                        
                                Mondra |  $13,206,500  | (Oct 30, 2025)
                                                                        
                                hoop.dev |  Undisclosed Amount  | (Oct 30, 2025)
                                                                        
                                FrontlineIQ |  $3,300,000  | (Oct 30, 2025)